4.8 Article

A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment

期刊

JOURNAL OF CONTROLLED RELEASE
卷 238, 期 -, 页码 31-42

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2016.07.024

关键词

pH-responsive liposomes; Tumour targeting; Protein delivery; Bladder cancer treatment

资金

  1. University of Padova [CPDA121714, CUP C94H12000020005]
  2. Associazione Italiana per la Ricerca sul Cancro/Fondazione Cariparo (AIRC Regional grant) [6421]
  3. Progetti di Ricerca di Ateneo [CPDA137871]
  4. Fondazione Cariplo [2011-0485]
  5. Progetto Giovani Studiosi of the University of Padova

向作者/读者索取更多资源

Stealth pH-responsive liposomes for the delivery of therapeutic proteins to the bladder epithelium were prepared using methoxy-poly(ethylene glycol)(5kDa)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (mPEG(5kDa)-DSPE) and stearoyl-poly(ethylene glycol)-poly(methacryloyl sulfadimethoxine) copolymer (stearoyl-PEG-polySDM), which possesses an apparent pKa of 7.2. Liposomes of 0.2:0.6:100, 0.5:1.5:100 and 1: 3: 100 mPEG(5kDa)-DSPE/stearoyl-PEG-polySDM/(soybean phosphatidylcholine + cholesterol) molar ratios were loaded with bovine serum albumin (BSA) as a protein model. The loading capacity was 1.3% w/w BSA/lipid. At pH 7.4, all liposome formulations displayed a negative zeta-potential and were stable for several days. By pH decrease or addition to mouse urine, the zeta potential strongly decreased, and the liposomes underwent a rapid size increase and aggregation. Photon correlation spectroscopy (PCS) and transmission electron microscopy (TEM) analyses showed that the extent of the aggregation depended on the stearoyl-PEG-polySDM/lipid molar ratio. Cytofluorimetric analysis and confocal microscopy showed that at pH 6.5, the incubation of MB49 mouse bladder cancer cells and macrophages with fluorescein isothiocyanate-labelled-BSA (FITC-BSA) loaded and N-(Lissamine Rhodamine B sulfonyl)-1, 2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (rhodamine-DHPE) labelled 1:3:100 mPEG(5kDa)-DSPE/stearoyl-PEG-polySDM/lipid molar ratio liposomes resulted in a time-dependent liposome association with the cells. At pH 7.4, the association of BSA-loaded liposomes with the MB49 cells and macrophages was remarkably lower than at pH 6.5. Confocal images of bladder sections revealed that 2 h after the instillation, liposomes at pH 7.4 and control non-responsive liposomes at pH 7.4 or 6.5 did not associate nor delivered FITC-BSA to the bladder epithelium. On the contrary, the pH-responsive liposome formulation set at pH 6.5 and soon administered to mice by bladder instillation showed that, 2 h after administration, the pH-responsive liposomes efficiently delivered the loaded FITC-BSA to the bladder epithelium. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation

Maria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, Fabio Canino, Carlo Alberto Giorgi, Enrico Cumerlato, Ottavia Amato, Davide Massa, Gaia Griguolo, Elisa Genovesi, Giovanna Garufi, Diana Giannarelli, Antonio Tornincasa, Lucia Trudu, Silvia Michieletto, Tania Saibene, Marcello Lo Mele, Matteo Fassan, Giovanni Zarrilli, Federico Piacentini, Emilio Bria, Valentina Guarneri

Summary: This study demonstrates that incorporating carboplatin into neoadjuvant chemotherapy significantly improves pathological complete response (pCR) in triple-negative breast cancer (TNBC) patients. Additionally, the combination of anthracycline-taxane chemotherapy with carboplatin enhances immune infiltration. Finally, the increase in tumor-infiltrating lymphocytes (TILs) after neoadjuvant chemotherapy exposure is independently associated with distant disease-free survival.

BRITISH JOURNAL OF CANCER (2023)

Correction Multidisciplinary Sciences

Patterns of somatic structural variation in human cancer genomes (vol 578, pg 112, 2020)

Yilong Li, Nicola D. Roberts, Jeremiah A. Wala, Ofer Shapira, Steven E. Schumacher, Kiran Kumar, Ekta Khurana, Sebastian Waszak, Jan O. Korbel, James E. Haber, Marcin Imielinski, Joachim Weischenfeldt, Rameen Beroukhim, Peter J. Campbell

NATURE (2023)

Correction Multidisciplinary Sciences

The evolutionary history of 2,658 cancers (vol 578, pg 122, 2020)

Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C. Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J. Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu, Maxime Tarabichi, Amit Deshwar, Jeff Wintersinger, Kortine Kleinheinz, Ignacio Vazquez-Garcia, Kerstin Haase, Lara Jerman, Subhajit Sengupta, Geoff Macintyre, Salem Malikic, Nilgun Donmez, Dimitri G. Livitz, Marek Cmero, Jonas Demeulemeester, Steven Schumacher, Yu Fan, Xiaotong Yao, Juhee Lee, Matthias Schlesner, Paul C. Boutros, David D. Bowtell, Hongtu Zhu, Gad Getz, Marcin Imielinski, Rameen Beroukhim, S. Cenk Sahinalp, Yuan Ji, Martin Peifer, Florian Markowetz, Ville Mustonen, Ke Yuan, Wenyi Wang, Quaid D. Morris, Paul T. Spellman, David C. Wedge, Peter Van Loo

NATURE (2023)

Correction Multidisciplinary Sciences

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (vol 578, pg 102, 2020)

Esther Rheinbay, Morten Muhlig Nielsen, Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshoj, Julian M. Hess, Randi Istrup Juul, Ziao Lin, Lars Feuerbach, Radhakrishnan Sabarinathan, Tobias Madsen, Jaegil Kim, Loris Mularoni, Shimin Shuai, Andres Lanzos, Carl Herrmann, Yosef E. Maruvka, Ciyue Shen, Samirkumar B. Amin, Pratiti Bandopadhayay, Johanna Bertl, Keith A. Boroevich, John Busanovich, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, David Craft, Priyanka Dhingra, Klev Diamanti, Nuno A. Fonseca, Abel Gonzalez-Perez, Qianyun Guo, Mark P. Hamilton, Nicholas J. Haradhvala, Chen Hong, Keren Isaev, Todd A. Johnson, Malene Juul, Andre Kahles, Abdullah Kahraman, Youngwook Kim, Jan Komorowski, Kiran Kumar, Sushant Kumar, Donghoon Lee, Kjong-Van Lehmann, Yilong Li, Eric Minwei Liu, Lucas Lochovsky, Keunchil Park, Oriol Pich, Nicola D. Roberts, Gordon Saksena, Steven E. Schumacher, Nikos Sidiropoulos, Lina Sieverling, Nasa Sinnott-Armstrong, Chip Stewart, David Tamborero, Jose M. C. Tubio, Husen M. Umer, Liis Uuskuela-Reimand, Claes Wadelius, Lina Wadi, Xiaotong Yao, Cheng-Zhong Zhang, Jing Zhang, James E. Haber, Asger Hobolth, Marcin Imielinski, Manolis Kellis, Michael S. Lawrence, Christian von Mering, Hidewaki Nakagawa, Benjamin J. Raphael, Mark A. Rubin, Chris Sander, Lincoln D. Stein, Joshua M. Stuart, Tatsuhiko Tsunoda, David A. Wheeler, Rory Johnson, Jueri Reimand, Mark Gerstein, Ekta Khurana, Peter J. Campbell, Nuria Lopez-Bigas, Joachim Weischenfeldt, Rameen Beroukhim, Inigo Martincorena, Jakob Skou Pedersen, Gad Getz

NATURE (2023)

Letter Cell Biology

Lynch syndrome-related colorectal carcinomas are NTRK-negative

Andrea Remo, Federica Grillo, Alessandro Vanoli, Paola Parente, Luca Mastracci, Valentina Angerilli, Emanuele Damiano Urso, Francesca Bergamo, Matteo Fassan

HISTOPATHOLOGY (2023)

Article Pathology

PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2-BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

Federica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Matteo Fassan

Summary: This study aims to track the dynamics of the PI3K/PTEN/mTOR pathway in HR+/HER2- breast cancer patients receiving neoadjuvant chemotherapy. The results show that this pathway is highly dynamic and may play a crucial role in shaping the molecular landscape of breast cancer with residual disease after chemotherapy.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Pathology

HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective

Valentina Angerilli, Paola Parente, Michela Campora, Clara Ugolini, Serena Battista, Paola Cassoni, Alessandro Gambella, Francesco Cavallin, Giuseppe De Lisi, Alessandro Vanoli, Federica Grillo, Luca Mastracci, Matteo Fassan

Summary: In this study, the clinicopathological and molecular features of HER2-low gastric/gastro-oesophageal junction cancers were investigated. It was found that HER2-low expression was more common in biopsy specimens and varied among different institutions. If further research confirms the effectiveness of novel anti-HER2 agents in HER2-low gastro-oesophageal cancers, the interpretation of HER2 status may need to be revised.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Oncology

Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells

Sibilla Molon, Paola Brun, Melania Scarpa, Dario Bizzotto, Gaia Zuccolotto, Marco Scarpa, Matteo Fassan, Imerio Angriman, Antonio Rosato, Paola Braghetta, Ignazio Castagliuolo, Paolo Bonaldo

Summary: The study investigates the role of collagen VI in the development of intestinal inflammation and finds that it plays an important role in lymphatic vessel development and intestinal inflammation. The study also reveals that high collagen VI expression in the colon biopsies of CD patients is associated with increased surgical risk and disease recurrence.

JOURNAL OF PATHOLOGY (2023)

Correction Biotechnology & Applied Microbiology

Butler enables rapid cloud-based analysis of thousands of human genomes (vol 38, pg 288, 2020)

Sergei Yakneen, Sebastian M. Waszak, Michael Gertz, Jan O. Korbel

NATURE BIOTECHNOLOGY (2023)

Article Genetics & Heredity

Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations

Andrea Remo, Federica Grillo, Luca Mastracci, Michele Simbolo, Matteo Fassan, Maria Paola Cecchini, Giuseppe Miscio, Antonio Sassano, Paola Parente, Alessandro Vanoli, Giovanna Sabella, Guido Giordano, Emanuele Damiano Urso, Luigi Cerulo, Aldo Scarpa, Francesco Fiorica, Massimo Pancione

Summary: A recent study explores the genetic and immunophenotypic characteristics of rhabdoid colorectal tumors (RCTs). The findings reveal that RCTs exhibit mismatch repair-deficient phenotypes, CK7-/CK20-/CDX2- marker phenotype, and aberrant activation of the MAPK pathway, particularly with BRAF V600E mutations. While SMARCB1/INI1 expression is normal, the ciliogenic markers CROCC and β-tubulin are globally altered in RCTs. Overall, these results indicate that primary ciliogenesis and MAPK pathway activation contribute to the aggressiveness of RCTs, suggesting a potential therapeutic target.
Review Oncology

IMMUNOREACT 0: Biopsy-based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer-A systematic review and meta-analysis

Astghik Stepanyan, Matteo Fassan, Gaya Spolverato, Ignazio Castagliuolo, Melania Scarpa, Marco Scarpa, IMMUNOREACT Study Grp

Summary: Neoadjuvant therapy (NT) followed by surgery is the main treatment for rectal cancer patients. Immune biomarkers are being recognized as potential predictors of NT response. A meta-analysis was performed to estimate their predictive significance.

CANCER MEDICINE (2023)

Article Oncology

Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?

Ottavia De Simoni, Luca Dal Santo, Marco Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Solda, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Matteo Fassan, Mario Gruppo

Summary: The aim of this study is to determine the potential significant tumor microenvironment (TME) immune markers of long-term survival in pancreatic ductal adenocarcinoma (PDAC) patients. Immunohistochemical staining was performed to characterize the TME using tissue microarray. The results showed that high density of CD8+ lymphocytes and low density of FOXP3+ and iNOS+ tumor-associated macrophages (TAMs) are predictors of good prognosis in PDAC patients.

CURRENT ONCOLOGY (2023)

Article Pathology

Preoperative endoscopy and pathology report of the specimen to be recommended in sleeve gastrectomy?

Remo Alessandris, Federico Moroso, Mauro Michelotto, Matteo Fassan, Valentina Angerilli, Linda Callegari, Mirto Foletto

Summary: The use of preoperative upper gastrointestinal endoscopy and postoperative histopathological examination in bariatric surgery is still controversial. Based on the clinical experience of the authors, both preoperative endoscopic assessment and postoperative histopathological examination of the specimen are recommended to provide optimal treatment for these patients.

PATHOLOGICA (2023)

Review Pathology

A practical approach for PD-L1 evaluation in gastroesophageal cancer

Valentina Angerilli, Matteo Fassan, Paola Parente, Irene Gullo, Michela Campora, Chiara Rossi, Maria Luisa Sacramento, Gianmaria Pennelli, Alessandro Vanoli, Federica Grillo, Luca Mastracci

Summary: PD-L1 is an established immunohistochemical biomarker for predicting the response to immunotherapy. However, it still has limitations due to changing cut-off values and scoring systems, as well as variability between observers and laboratories. This review focuses on the staining patterns and challenges in evaluating PD-L1 in gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma.

PATHOLOGICA (2023)

Review Pathology

FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice

Valentina Angerilli, Lorenzo Fornaro, Francesco Pepe, Silvia Maria Rossi, Giuseppe Perrone, Umberto Malapelle, Matteo Fassan

Summary: Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms with a poor prognosis. FGFR2 fusions/rearrangements are druggable genetic alterations in a subset of CCAs. Standardization of molecular testing for FGFR2 alterations in CCA is necessary with the emergence of FGFR-targeting therapies.

PATHOLOGICA (2023)

Review Chemistry, Multidisciplinary

Polymer mechanochemistry in drug delivery: From controlled release to precise activation

Zhiyuan Shi, Yong Hu, Xin Li

Summary: Controlled drug delivery systems that can respond to mechanical force offer a unique solution for on-demand drug activation and release. Among various mechanical stimuli, ultrasound (US) has advantages in achieving spatiotemporally controlled drug release. Traditional US-triggered drug release relies on heat-induced phase transitions or chemical transformations, while the cutting-edge approach of Sonopharmacology leverages polymer mechanochemistry. The remaining challenges and potential future directions in this field are also discussed.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis

Lijie Zheng, Yuanzheng Chen, Xun Gu, Yingying Li, Hanqing Zhao, Wenjun Shao, Tao Ma, Chuanbin Wu, Qingqing Wang

Summary: In this study, a novel dosage form consisting of dissolving microneedles and an adhesive transdermal patch was developed for the treatment of rheumatoid arthritis. In vitro and in vivo experiments demonstrated that the combination of drugs delivered by this dosage form effectively reduced joint inflammation and damage.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides

Kyungjik Yang, Hwa Seung Han, Seung Hwan An, Kyung Hoon Park, Keonwook Nam, Shinha Hwang, Yuyeon Lee, Sung Yeon Cho, Taehyung Kim, Deokyeong Choe, Sang Won Kim, Wonkyu Yu, Hyunah Lee, Jiyong Park, Sangguan You, Dong- Gyu Jo, Ki Young Choi, Young Hoon Roh, Jae Hyung Park

Summary: This study developed CP-loaded CS microcapsules to enhance the oral bioavailability of CP through controlled gastrointestinal delivery. The optimized microcapsules exhibited desirable physicochemical properties, showed anti-photoaging effects via antioxidant activity, and achieved controlled release in the gastrointestinal tract. This research provides a simple and economical approach for enhancing the oral bioavailability of CP for customized bioactive compound administration.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema

Huiyang Li, Shuo Liu, Wenjin Dai, Bingmei Yao, Yong Zhou, Sujia Si, Hairong Yu, Riguang Zhao, Fang Jin, Liqun Jiang

Summary: Changes in bodily fluid pressures are crucial in diseases like high-altitude pulmonary edema (HAPE). Researchers have developed hydrostatic pressure-sensitive multivesicular liposomes (PSMVLs) that can release drugs in response to pressure changes, with potential applications in HAPE treatment. Animal experiments showed that this system provides better protection for lung tissues and respiratory function, reducing the occurrence of pulmonary edema.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia

Qian Hu, Hongbing Lan, Yinmei Tian, Xiaonan Li, Mengmeng Wang, Jiao Zhang, Yulin Yu, Wei Chen, Li Kong, Yuanyuan Guo, Zhiping Zhang

Summary: Coacervate droplets formed through liquid-liquid phase separation have potential as delivery vesicles for therapeutics. However, their lack of physiological stability and membranes are challenges. In this study, polylysine-polynucleotide complex coacervate droplets with favorable stability were formulated to concentrate molecules and nanoparticles. Phospholipid membranes were further coated on the droplets to create coacervate-based artificial protocells (ArtPC) with membrane-like structures. These biofunctional ArtPC effectively reduced blood uric acid levels and prevented renal injuries.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer

Xiaowei Wang, Hongwei Lu, Fang Luo, Dan Wang, Apeng Wang, Xuelei Wang, Wenkai Feng, Xiaobo Wang, Jiayi Su, Mingliang Liu, Guimin Xia

Summary: Four novel lipid-like GEM diesters were synthesized and encapsulated into liposomes to improve the antitumor efficacy of Gemcitabine. The liposomes loaded with dimyristoyl GEM (LipodmGEM) showed enhanced cellular uptake, improved inhibition of cell migration, and a greatly extended half-life compared to free Gemcitabine. LipodmGEM successfully enriched the drug in the tumor and exhibited excellent anticancer efficacy in vivo with negligible systemic toxicity.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment

Pengyu Li, Jieyi Pan, Yating Dong, Yingying Sun, Yalong Wang, Kang Liao, Yili Chen, Xin Deng, Shihui Yu, Haiyan Hu

Summary: Chronic pulmonary infection caused by Pseudomonas aeruginosa is a serious public health problem with high mortality rates. In this study, infection-microenvironment responsive nanoparticles were developed to eradicate biofilms and inhibit virulence. These nanoparticles showed promising results in treating chronic pulmonary infections.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Yajing Sun, Ze Lu, John A. Taylor, Jessie L. S. Au

Summary: A recent development in cancer chemotherapy is the use of cytotoxics to induce tumor-specific immune response through immunogenic cell death (ICD). This study describes a method that utilizes immunostaining and machine-learning to identify cells with ecto-CRT in intact 3-dimensional tissues. The method was successfully applied to study drug-induced ICD in human bladder cancer.

JOURNAL OF CONTROLLED RELEASE (2024)

Review Chemistry, Multidisciplinary

Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation

Rafat Ali, Shantanu Sen, Rohil Hameed, Aamir Nazir, Sandeep Verma

Summary: This review provides a focused overview of emerging strategies for delivering gasotransmitters in a controlled and sustained manner to reestablish neurophysiological homeostasis.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Multifunctional hydrogel for synergistic reoxygenation and chemo/ photothermal therapy in metastatic breast cancer recurrence and wound infection

Jing Chen, Xinyi Zhang, Jinshen Zhang, Zhaoxia Wang, Guilan Zhu, Ming Geng, Jinmiao Zhu, Yajun Chen, Wei Wang, Youcui Xu

Summary: In this study, a multifunctional responsive hydrogel system was developed for synergistic reoxygenation and chemo/photothermal therapy. The hydrogel system showed both therapeutic effects against metastatic breast cancer and wound infection, making it a promising strategy for treating and preventing tumor recurrence and associated wound infection.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: Inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation

Baoshan Huang, Na Zhang, Xinying Qiu, Rui Zeng, Shuimiao Wang, Mengxia Hua, Qing Li, Kaihui Nan, Sen Lin

Summary: This study revealed that robust ROS can oxidize mitochondrial DNA (ox-mtDNA) and cause its release into the cytosol, resulting in the activation of NLRP3 inflammasome. By using the mitochondria-targeted antioxidant SkQ1 and a novel mitochondria-targeted nanoparticle (SkQ1 NP), it was found that mitochondrial ROS scavenging could in situ inhibit DED-induced mtDNA oxidation and suppress NLRP3-mediated inflammation.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction

Wenqi Liu, Cheng Hu, Linyu Long, Shuyi He, Wen Zhang, Zhicun Wang, Li Yang, Yunbing Wang

Summary: Myocardial infarction is the leading cause of cardiovascular mortality, and current treatment methods have limitations. This study developed a smart carrier that can release different therapeutic substances for different pathological processes, effectively improving cardiac function, promoting cardiac repair, and preventing ventricular remodeling.

JOURNAL OF CONTROLLED RELEASE (2024)